Lehrstuhl für Geburtshilfe und Frauenheilkunde

Address:
Universitätsstraße 21/23
91054 Erlangen



Subordinate Organisational Units

Professur für Experimentelle Reproduktionsmedizin
Professur für Translationale Frauenheilkunde und Geburtshilfe


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 15 Go to next page Go to last page

Krebs, J., Wasner, S., Egloffstein, S., Lux, M.P., Morawa, E., Beckmann, M., & Erim, Y. (2018). Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion. Psychotherapie Psychosomatik Medizinische Psychologie. https://dx.doi.org/10.1055/a-0668-1206
Eichler, A., Hudler, L., Grunitz, J., Grimm, J., Raabe, E., Goecke, T.W.,... Heinrich, H. (2018). Effects of prenatal alcohol consumption on cognitive development and ADHD-related behaviour in primary-school age: a multilevel study based on meconium ethyl glucuronide. The journal of child psychology and psychiatry, 59(2), 110-118. https://dx.doi.org/10.1111/jcpp.12794
Gaß, P., Lux, M.P., Rauh, C., Hein, A., Bani, M., Fiessler, C.,... Wunderle, M. (2018). Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer. Bmc Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4925-1
Schink, K., Herrmann, H.J., Schwappacher, R., Orlemann, T., Meyer, J., Waldmann, E.,... Zopf, Y. (2018). Whole-Body Electromyostimulation combined with personalized Nutritional Support improves the Body Composition of Patients with advanced Cancer. (pp. S67-S67).
Gebrekidan, M., Erber, R., Hartmann, A., Fasching, P.A., Emons, J., Beckmann, M., & Bräuer, A. (2018). Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS). Technology in Cancer Research & Treatment, 17. https://dx.doi.org/10.1177/1533033818782532
Grafe, C., Semrau, S., Hein, A., Beckmann, M., Mackensen, A., Dörje, F., & Fromm, M. (2018). Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety. Naunyn-Schmiedebergs Archives of Pharmacology, 391(2), 219-229. https://dx.doi.org/10.1007/s00210-017-1456-2
Painter, J.N., O'Mara, T.A., Morris, A.P., Cheng, T.H.T., Gorman, M., Martin, L.,... Spurdle, A.B. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Medicine, 7(5), 1978-1987. https://dx.doi.org/10.1002/cam4.1445
Huebner, H., Knoerr, B., Betzler, A., Hartner, A., Kehl, S., Baier, F.,... Rübner, M. (2018). Detyrosinated tubulin is decreased in fetal vessels of preeclampsia placentas. Placenta, 62, 58-65. https://dx.doi.org/10.1016/j.placenta.2017.12.019
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05427-7
Brennan, M., Gaß, P., Häberle, L., Wang, D., Hartmann, A., Lux, M.P.,... Fasching, P.A. (2018). The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer. Breast Cancer Research and Treatment, 171(3), 747-758. https://dx.doi.org/10.1007/s10549-018-4829-4
Gaß, P., Untch, M., Mueller, V., Moebus, V., Thomssen, C., Häberle, L.,... Nabieva, N. (2018). Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians. Geburtshilfe und Frauenheilkunde, 78(7), 707-714. https://dx.doi.org/10.1055/a-0642-9462
Siegler, L., Erber, R., Burghaus, S., Brodkorb, T., Wachter, D., Wilkinson, N.,... Agaimy, A. (2018). Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Archiv. https://dx.doi.org/10.1007/s00428-018-2292-6
Hoyer, J., Vasileiou, G., Uebe, S., Wunderle, M., Kraus, C., Fasching, P.A.,... Reis, A. (2018). Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria. Bmc Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4821-8
Wunderle, M., Gaß, P., Häberle, L., Flesch, V.M., Rauh, C., Bani, M.,... Hein, A. (2018). BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients. Breast Cancer Research and Treatment, 171(1), 85-94. https://dx.doi.org/10.1007/s10549-018-4797-8
Erber, R., Hartmann, A., Beckmann, M., Mackensen, A., Kremer, A., Reimann, H.,... Fasching, P.A. (2018). TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes. Pathologe, 39(Suppl 2), 236-240. https://dx.doi.org/10.1007/s00292-018-0526-7
Schink, K., Herrmann, H.J., Schwappacher, R., Meyer, J., Orlemann, T., Waldmann, E.,... Zopf, Y. (2018). Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial. Bmc Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4790-y
Wunderle, M., Olmes, G., Nabieva, N., Häberle, L., Jud, S., Hein, A.,... Fasching, P.A. (2018). Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. Geburtshilfe und Frauenheilkunde, 78(5), 481-492. https://dx.doi.org/10.1055/a-0603-4350
Poehls, U.G., Hack, C., Ekici, A.B., Beckmann, M., Fasching, P.A., Rübner, M., & Hübner, H. (2018). Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. European Journal of Medical Research, 23(1). https://dx.doi.org/10.1186/s40001-018-0318-9
Schlichtig, K., Lechner, P., Grafe, C., Ferstl, B., Fuchs, F., Hein, A.,... Dorje, F. (2018). Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN. (pp. 198-198).
Emons, J., Wunderle, M., Hartmann, A., Radicke, M., Rauh, C., Uder, M.,... Jud, S. (2018). Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probe. Acta Radiologica, 59(12), 1406-1413. https://dx.doi.org/10.1177/0284185118762249

Last updated on 2016-05-05 at 04:59